Stock / equity
IBIT iShares Bitcoin Trust ETF
- Security
- Equity
- Members of Congress
- 3
- Latest trade on record
- March 4, 2026
IBIT (iShares Bitcoin Trust ETF) has 0 disclosed insider transactions from 0 insiders in the last 12 months (0 open-market buys, 0 sales, about $0 at reported prices) and 4 congressional trades from 3 members of Congress. The most recent disclosure was filed April 16, 2026.
Share price
Price and chart by TradingView for iShares Bitcoin Trust ETF. US share prices here are delayed, not real-time. The trade records on this page come from government filings, not from this chart.
IBIT in charts
Who is trading this stock
Which people account for the buying and selling over the last 12 months?
3 people account for the disclosed buying and selling in IBIT over the last 12 months; the most active is Rep. Sheri Biggs with $250K.
Members of Congress trading IBIT
Members whose periodic transaction reports name this ticker. Amounts are the sums of the ranges as filed.
| Member | Seat | Trades | Bought | Sold | Range as filed | Latest |
|---|---|---|---|---|---|---|
| Marjorie Taylor Greene | Representative (GA, District 14), Republican | 4 | 4 | 0 | $4,004–$60K | November 21, 2025 |
| Sheri Biggs | Representative (SC, District 3), Republican | 2 | 2 | 0 | $200K–$500K | March 4, 2026 |
| Brandon Gill | Representative (TX, District 26), Republican | 1 | 1 | 0 | $15K–$50K | October 29, 2025 |
Insider transactions
No Form 4 transactions for this ticker in the tracked window yet.
Congressional trades
| Filer | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Sheri Biggs | Buy | March 4, 2026 | April 16, 2026 | 43d | — | — | $100K–$250K | spouse | House PTR ↗ | |
| Marjorie Taylor Greene | Buy | November 21, 2025 | December 2, 2025 | 11d | — | — | $1,001–$15K | House PTR ↗ | ||
| Brandon Gill | Buy | October 29, 2025 | November 18, 2025 | 20d | — | — | $15K–$50K | House PTR ↗ | ||
| Marjorie Taylor Greene | Buy | October 24, 2025 | October 28, 2025 | 4d | — | — | $1,001–$15K | House PTR ↗ | ||
| Marjorie Taylor Greene | Buy | October 9, 2025 | October 20, 2025 | 11d | — | — | $1,001–$15K | House PTR ↗ | ||
| Marjorie Taylor Greene | Buy | October 15, 2025 | October 20, 2025 | 5d | — | — | $1,001–$15K | House PTR ↗ | ||
| Sheri Biggs | Buy | July 9, 2025 | October 5, 2025 | 88d | — | — | $100K–$250K | latespouse | House PTR ↗ |
Related stocks
Tickers traded by the same people who traded IBIT, by number of filers in common. It shows overlap in public filings and nothing else.
- CVX Chevron Corporation Common Stock 2 filers in common
- MSFT Microsoft Corporation - Common Stock 2 filers in common
- PAYX Paychex, Inc. - Common Stock 2 filers in common
- UPS United Parcel Service, Inc. Common Stock 2 filers in common
- BRK.B Berkshire Hathaway Inc. New Common Stock 2 filers in common
- NFLX Netflix, Inc. - Common Stock 1 filer in common
- ADBE Adobe Inc. - Common Stock 1 filer in common
- AMZN Amazon.com, Inc. - Common Stock 1 filer in common
Guides for this page
- How to read a congressional trade report Owner tells you whose asset it was: the member, the spouse, a dependent child, or held jointly.
- Why congressional trade amounts are ranges There are ten ranges; the lowest is $1,001–$15,000 and the highest is over $50,000,000.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| House Clerk, periodic transaction reports | 6 | 7 | October 5, 2025 | April 16, 2026 | House Clerk search |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Insider rows are Form 4 filings for this issuer from SEC EDGAR; congressional rows are periodic transaction reports parsed from the House Clerk and the Senate eFD. Values use the reported price for Form 4 and the disclosed range for Congress. See methodology and corrections.
Not investment advice. Disclosures are shown as filed and may lag the trade or be amended. No recommendation is made or implied.